Free Trial

Thermo Fisher Scientific (TMO) News Today

Thermo Fisher Scientific logo
$479.48 -11.93 (-2.43%)
Closing price 09/12/2025 03:59 PM Eastern
Extended Trading
$482.50 +3.02 (+0.63%)
As of 09/12/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is Thermo Fisher Scientific Down Today?

Thermo Fisher Scientific (NYSE:TMO) shares fell amid a mix of analyst upgrades and earnings‐estimate revisions, along with a small insider sale. Key developments for investors:

  • Positive Sentiment: Barclays upgraded TMO from “equal weight” to “overweight” and raised its price target to $550 from $490, implying roughly 15% upside. Barclays Upgrade Article
  • Positive Sentiment: Analysts collectively lifted their consensus price target to $589.38, reflecting stronger outlook. Consensus PT Article
  • Positive Sentiment: Zacks Research nudged its Q2 2027 EPS estimate up to $7.11 from $7.10. Zacks Q2 Forecast Article
  • Positive Sentiment: Zacks also raised its Q4 2026 EPS outlook to $6.51 from $6.50. MarketBeat
  • Positive Sentiment: Investing.com notes TMO’s attractive valuation and clear growth visibility, underpinning a bullish stance. Bullish View Article
  • Neutral Sentiment: Benzinga compiled perspectives from 11 analysts on TMO, offering mixed insights without a unified direction. Analyst Discussion Article
  • Neutral Sentiment: Yahoo Finance lists TMO among one healthcare pick for long-term investors, alongside other sector names. Yahoo Finance Article
  • Negative Sentiment: CEO Marc Casper sold 400 shares at $500.50, trimming his stake by 0.35%. Insider Sale Article
  • Negative Sentiment: Zacks cut its Q2 2026 EPS estimate to $5.92 from $6.01. MarketBeat
  • Negative Sentiment: Zacks trimmed its FY 2027 EPS forecast to $27.13 from $27.17. MarketBeat
  • Negative Sentiment: Zacks lowered its FY 2026 EPS view to $24.13 from $24.21. MarketBeat

In sum, while upgraded targets and modest earnings boosts support the shares, estimate cuts and an insider sale add caution. Investors should monitor upcoming Q3 guidance and Pfizer–license developments for further direction.

Posted 15h agoAI Generated. May Contain Errors.

TMO Latest News

Thermo Fisher Scientific (NYSE:TMO) Upgraded at Barclays
Barclays Upgrades Thermo Fisher Scientific (TMO)
What is Zacks Research's Forecast for TMO Q2 Earnings?
1 Healthcare Stock for Long-Term Investors and 2 We Brush Off
Best Biotech Stocks To Follow Today - September 8th
Here’s What Dragged Thermo Fisher Scientific (TMO) in Q2
Thermo Fisher Scientific (NYSE:TMO) CEO Sells $200,200.00 in Stock
Thermo Fisher Expands Reach with Solventum Buy
Get Thermo Fisher Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMO Media Mentions By Week

TMO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TMO
News Sentiment

1.26

0.93

Average
Medical
News Sentiment

TMO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TMO Articles
This Week

64

49

TMO Articles
Average Week

Get the Latest News and Ratings for TMO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NYSE:TMO) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners